| 000 | 01121 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517221701.0 | ||
| 264 | 0 | _c20190118 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1744-7631 | ||
| 024 | 7 |
_a10.1080/14728222.2018.1482279 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNovak, James S | |
| 245 | 0 | 0 |
_aThe macrophage as a Trojan horse for antisense oligonucleotide delivery. _h[electronic resource] |
| 260 |
_bExpert opinion on therapeutic targets _c06 2018 |
||
| 300 |
_a463-466 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aGene Transfer Techniques |
| 650 | 0 | 4 |
_aGenetic Therapy _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMacrophages _xmetabolism |
| 650 | 0 | 4 |
_aOligonucleotides, Antisense _xadministration & dosage |
| 700 | 1 | _aJaiswal, Jyoti K | |
| 700 | 1 | _aPartridge, Terence A | |
| 773 | 0 |
_tExpert opinion on therapeutic targets _gvol. 22 _gno. 6 _gp. 463-466 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/14728222.2018.1482279 _zAvailable from publisher's website |
| 999 |
_c28489470 _d28489470 |
||